Exclusive special offer and discount title banner vector image

ASIA-PACIFIC BIOPSY DEVICES MARKET FORECAST 2024-2032

SCOPE OF THE REPORT

Asia-Pacific Biopsy Devices Market by Product (Needle-Based Biopsy Guns (Vacuum-Assisted Biopsy Devices, Fine Needle Aspiration Biopsy Devices, Core Needle Biopsy Devices), Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps, Other Products) Market by Application (Oncology, Gastroenterology, Pulmonology, Dermatology, Other Applications) Market by End Use (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers) by Geography


MARKET OVERVIEW

The Asia-Pacific biopsy devices market is evaluated to grow at a CAGR of 8.38% over the forecast period of 2024-2032 and is set to reach a revenue of $xx million by 2032

The Asia-Pacific biopsy devices market is transitioning with substantial growth, fueled by an emphasis on personalized medicine, a medical approach that customizes treatment plans to individual patient characteristics. This emphasis has led to an increased demand for advanced biopsy devices, which are integral in diagnosing diseases and formulating precise, individualized treatment strategies. As healthcare in the Asia-Pacific continues to evolve towards more personalized approaches, biopsy devices are expected to be integral in supporting accurate diagnoses and targeted treatments.

Another contributing factor to the growth of the market is the shift towards preventive healthcare. With an increasing awareness of the importance of early detection and prevention of diseases, there has been a rising emphasis on regular health check-ups and screenings. This trend has fueled the demand for advanced biopsy devices, as they are vital in the early diagnosis of various medical conditions.

Asia-Pacific Biopsy Devices Market

To Know More About This Report, Request a Free Sample Copy

Furthermore, the market is benefiting from continuous advancements in biopsy technology. The Asia-Pacific has been at the forefront of embracing and implementing transformative technologies in the healthcare sphere. The ongoing advancements in biopsy technology have resulted in more accurate and less invasive procedures, making biopsy devices more effective and efficient. These technological developments contribute significantly to the overall growth and competitiveness of the biopsy devices market in the Asia-Pacific. As a result, these factors are set to stimulate the market’s growth in Asia-Pacific during the forecast period.

The Asia-Pacific biopsy devices market segmentation includes product, application, and end use. The product segment incorporates needle-based biopsy guns, biopsy guidance systems, biopsy needles, biopsy forceps, and other products. Biopsy needles are important in medical procedures, enabling clinicians to extract tissue samples for diagnostic purposes. The demand for biopsy needles in the Asia-Pacific is on the rise, driven by the increasing prevalence of diseases requiring biopsy-based diagnostics and the continuous advancements in needle technologies, enhancing precision and minimizing invasiveness.

Another significant component within the product segmentation is biopsy forceps. Biopsy forceps are instrumental in embracing and extracting tissue samples during medical procedures. The region has witnessed growing adoption of biopsy forceps due to their efficacy in obtaining quality samples for accurate diagnostic assessments. The continuous refinement of biopsy forceps designs and materials contribute to their increased utilization in various medical settings, further boosting the overall growth of the biopsy devices market in the region.

Likewise, biopsy needles and biopsy forceps collectively contribute to advancing medical practices by providing healthcare professionals with the tools necessary for accurate and minimally invasive tissue sampling. As technology continues to evolve, further innovations in these product sub-segments are anticipated, driving the ongoing growth and development of the Asia-Pacific biopsy devices market.

Some of the leading players in the Asia-Pacific biopsy devices market are Cook Medical, Inrad Inc, Hologic Inc, Cardinal Health, Boston Scientific, etc. 

Hologic Inc, based in Marlborough, Massachusetts, is a prominent medical technology firm specializing in women’s health solutions. Operating globally, including in the Asia-Pacific, Hologic is dedicated to developing advanced diagnostic and surgical products. Since 2009, Hologic has maintained a presence in Hong Kong, demonstrating its commitment to addressing the healthcare needs of women. The facilities in Hong Kong mirror those in Boston, Massachusetts, London, Brussels, and the UK.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2024-2032
Base Year2023
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments Analyzed
Product, Application, and End Use
Countries AnalyzedChina, Japan, India, South Korea, Taiwan, Singapore, Australia & New Zealand, and Rest of Asia-Pacific
Companies AnalyzedCardinal Health, Hologic Inc, Danaher Corporation, Conmed Corporation, Cook Medical, DTR Medical, Inrad Inc, Boston Scientific, Medtronic PLC, Becton Dickinson and Company, Mammotome, Argon Medical Devices
TABLE OF CONTENTS 
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON BIOPSY DEVICES MARKET
    5. MAJOR MARKET FINDINGS
      1. GROWING EMPHASIS ON PERSONALIZED MEDICINE
      2. EXPANDING APPLICATIONS ACROSS MEDICAL SPECIALITIES
      3. DEVELOPMENT OF COST-EFFECTIVE BIOPSY SOLUTIONS
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. RISING PREVALENCE OF CANCER
      2. INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES
      3. SURGE IN THE NUMBER OF HOSPITALS AND DIAGNOSTIC CENTERS
    2. KEY RESTRAINTS
      1. HIGH RISK OF INFECTION FOR PATIENTS
      2. HIGH COST OF BIOPSY PROCEDURES
      3. LACK OF SKILLED PROFESSIONALS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
      1. SURGE IN THE HEALTHCARE EXPENDITURE
      2. SHIFT TOWARDS PREVENTIVE HEALTHCARE
      3. ADVANCEMENTS IN BIOPSY TECHNOLOGY
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTIONS
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
    4. VALUE CHAIN ANALYSIS
      1. RAW MATERIALS
      2. MANUFACTURERS
      3. DISTRIBUTION
      4. END-USERS
  5. MARKET BY PRODUCT
    1. NEEDLE-BASED BIOPSY GUNS
      1. VACUUM-ASSISTED BIOPSY (VAB) DEVICES
      2. FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES
      3. CORE NEEDLE BIOPSY (CNB) DEVICES
    2. BIOPSY GUIDANCE SYSTEMS
    3. BIOPSY NEEDLES
    4. BIOPSY FORCEPS
    5. OTHER PRODUCTS
  6. MARKET BY APPLICATION
    1. ONCOLOGY
    2. GASTROENTEROLOGY
    3. PULMONOLOGY
    4. DERMATOLOGY
    5. OTHER APPLICATIONS
  7. MARKET BY END USE
    1. HOSPITALS
    2. AMBULATORY SURGICAL CENTERS
    3. DIAGNOSTIC CENTERS
  8. GEOGRAPHICAL ANALYSIS
    1. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. ASIA-PACIFIC BIOPSY DEVICES MARKET DRIVERS
      3. ASIA-PACIFIC BIOPSY DEVICES MARKET CHALLENGES
      4. KEY PLAYERS IN ASIA-PACIFIC BIOPSY DEVICES MARKET
      5. COUNTRY ANALYSIS
        1. CHINA
        2. JAPAN
        3. INDIA
        4. SOUTH KOREA
        5. TAIWAN
        6. SINGAPORE
        7. AUSTRALIA & NEW ZEALAND
        8. REST OF ASIA-PACIFIC
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. CARDINAL HEALTH
      2. HOLOGIC INC
      3. DANAHER CORPORATION
      4. CONMED CORPORATION
      5. COOK MEDICAL
      6. DTR MEDICAL
      7. INRAD INC
      8. BOSTON SCIENTIFIC
      9. MEDTRONIC PLC
      10. BECTON DICKINSON AND COMPANY
      11. MAMMOTOME
      12. ARGON MEDICAL DEVICES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – BIOPSY DEVICES

TABLE 2: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 4: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 6: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 8: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY END USE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY END USE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 10: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 12: KEY PLAYERS OPERATING IN ASIA-PACIFIC BIOPSY DEVICES MARKET

TABLE 13: LIST OF MERGERS & ACQUISITIONS

TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 15: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 16: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING 

FIGURE 4: VALUE CHAIN ANALYSIS

FIGURE 5: ASIA-PACIFIC BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023

FIGURE 6: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, 2024-2032 (IN $ MILLION)

FIGURE 7: ASIA-PACIFIC BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY NEEDLE-BASED BIOPSY GUNS, IN 2023

FIGURE 8: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY VACUUM-ASSISTED BIOPSY (VAB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 10: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY (CNB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY BIOPSY GUIDANCE SYSTEMS, 2024-2032 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY BIOPSY NEEDLES, 2024-2032 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY BIOPSY FORCEPS, 2024-2032 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023

FIGURE 16: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 17: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY GASTROENTEROLOGY, 2024-2032 (IN $ MILLION)

FIGURE 18: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY PULMONOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 19: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY DERMATOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 20: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY OTHER APPLICATIONS, 2024-2032 (IN $ MILLION)

FIGURE 21: ASIA-PACIFIC BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY END USE, IN 2023

FIGURE 22: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)

FIGURE 23: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY AMBULATORY SURGICAL CENTERS, 2024-2032 (IN $ MILLION)

FIGURE 24: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY DIAGNOSTIC CENTERS, 2024-2032 (IN $ MILLION)

FIGURE 25: ASIA-PACIFIC BIOPSY DEVICES MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)

FIGURE 26: CHINA BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 27: JAPAN BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 28: INDIA BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 29: SOUTH KOREA BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 30: TAIWAN BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 31: SINGAPORE BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 32: AUSTRALIA & NEW ZEALAND BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 33: REST OF ASIA-PACIFIC BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FAQ’s